Direkt zum Inhalt springen
Study - Selective laser sintering 3D printing

News -

Study - Selective laser sintering 3D printing

Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron

Losan Pharma and FabRx have demonstrated the potential of selective laser sintering 3D printing to fabricate orodispersible printlets with characteristics similar to a commercial orally disintegrating tablet, but with the added benefit of using a manufacturing technology able to prepare medicines individualized to the patient.

The study was published in Pharmaceutics 2020, 12, 110.

Links

Kategorien

Kontakt

Zugehörige Meldungen

  • Review of our 4th Drug Delivery Conference

    Review of our 4th Drug Delivery Conference

    Attendees from over 20 countries joined our virtual Scientific Drug Delivery Conference 2022 on Tuesday 15th February to learn about topics specifically related to drug delivery, about nanotechnology and 3D printing. We would like to express our heartfelt thanks to each of the speakers as well as to the participants who gave their time to attend and to contribute.